Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome (ARDS) is a well-described disease process that can have numerous underlying causes, is commonly seen in the critical care setting, and is often under-recognized. ARDS is characterized by pulmonary edema with refractory hypoxemia, and was traditionally associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Fawaz, Koffman, Lauren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122525/
http://dx.doi.org/10.1007/978-981-13-3390-3_26
_version_ 1783515437131104256
author Ahmad, Fawaz
Koffman, Lauren
author_facet Ahmad, Fawaz
Koffman, Lauren
author_sort Ahmad, Fawaz
collection PubMed
description Acute Respiratory Distress Syndrome (ARDS) is a well-described disease process that can have numerous underlying causes, is commonly seen in the critical care setting, and is often under-recognized. ARDS is characterized by pulmonary edema with refractory hypoxemia, and was traditionally associated with a high mortality rate. The past few decades have generated many studies examining therapeutic interventions for ARDS; however, there are few Level 1 evidence-based interventions to this day that have been shown to improve mortality and outcomes. Lung protective ventilation remains the most studied and evidence-based intervention for the treatment of ARDS.
format Online
Article
Text
id pubmed-7122525
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-71225252020-04-06 Acute Respiratory Distress Syndrome Ahmad, Fawaz Koffman, Lauren Textbook of Neuroanesthesia and Neurocritical Care Article Acute Respiratory Distress Syndrome (ARDS) is a well-described disease process that can have numerous underlying causes, is commonly seen in the critical care setting, and is often under-recognized. ARDS is characterized by pulmonary edema with refractory hypoxemia, and was traditionally associated with a high mortality rate. The past few decades have generated many studies examining therapeutic interventions for ARDS; however, there are few Level 1 evidence-based interventions to this day that have been shown to improve mortality and outcomes. Lung protective ventilation remains the most studied and evidence-based intervention for the treatment of ARDS. 2018-12-08 /pmc/articles/PMC7122525/ http://dx.doi.org/10.1007/978-981-13-3390-3_26 Text en © Springer Nature Singapore Pte Ltd. 2019 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Ahmad, Fawaz
Koffman, Lauren
Acute Respiratory Distress Syndrome
title Acute Respiratory Distress Syndrome
title_full Acute Respiratory Distress Syndrome
title_fullStr Acute Respiratory Distress Syndrome
title_full_unstemmed Acute Respiratory Distress Syndrome
title_short Acute Respiratory Distress Syndrome
title_sort acute respiratory distress syndrome
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122525/
http://dx.doi.org/10.1007/978-981-13-3390-3_26
work_keys_str_mv AT ahmadfawaz acuterespiratorydistresssyndrome
AT koffmanlauren acuterespiratorydistresssyndrome

Ejemplares similares